Dishman Carbogen Amcis announced that its wholly owned subsidiary based in Switzerland, Carbogen Amics AG has successfully completed a Swissmedic inspection of its Vionnaz facility, reaffirming the site`s compliance with high regulatory standards. Swissmedic, the Swiss Agency for Therapeutic Products, conducted a routine two-day inspection at the company`s Vionnaz site in Switzerland from 13 to 14 November 2024. Led by an inspector from the Regional Medicines Inspectorate of Western Switzerland (ISOPTh), the inspection focused on the Quality Management System compliance for the development and manufacture of highly potent APIs, including analytical and quality control processes. The site`s GMP Certification has been successfully renewed. Powered by Capital Market - Live News

Net profit of Dishman Carbogen Amcis reported to Rs 33.09 crore in the quarter ended September 2024 as against net loss of Rs 40.90 crore during the previous quarter ended September 2023. Sales rose 34.51% to Rs 789.04 crore in the quarter ended September 2024 as against Rs 586.59 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales789.04586.59 35 OPM %18.6510.37 - PBDT117.1741.83 180 PBT45.08-33.21 LP NP33.09-40.90 LP Powered by Capital Market - Live News

Dishman Carbogen Amcis will hold a meeting of the Board of Directors of the Company on 13 November 2024Powered by Capital Market - Live News

Dishman Carbogen Amcis announced that the 17th Annual General Meeting (AGM) of the company will be held on 27 September 2024.Powered by Capital Market - Live News

Net loss of Dishman Carbogen Amcis reported to Rs 77.57 crore in the quarter ended June 2024 as against net profit of Rs 17.00 crore during the previous quarter ended June 2023. Sales declined 27.59% to Rs 523.78 crore in the quarter ended June 2024 as against Rs 723.38 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales523.78723.38 -28 OPM %5.5316.85 - PBDT-1.5399.94 PL PBT-72.1229.49 PL NP-77.5717.00 PL Powered by Capital Market - Live News